Form 4: Phillip Frost Acquires 125,000 Shares of OPKO Health
SEC Form 4 Filing
Phillip Frost, CEO and Chairman of OPKO Health, Inc., purchased 125,000 shares of common stock at a weighted average price of $1.4772 on April 8, 2025.
Summary
- On April 8, 2025, Phillip Frost, the CEO and Chairman of OPKO Health, Inc., acquired 125,000 shares of OPKO's common stock.
- The shares were purchased at a weighted average price of $1.4772 per share, with individual transactions ranging from $1.46 to $1.495.
- Following the transaction, Dr. Frost directly owns 3,568,951 shares.
- Dr. Frost also has indirect ownership through Frost Gamma Investments Trust (213,876,448 shares) and Frost Nevada Investments Trust (30,127,177 shares).
- Dr. Frost disclaims beneficial ownership of the indirectly held securities except to the extent of any pecuniary interest.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. It reflects insider confidence, but it's a routine transaction.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued. However, it's just one factor to consider when evaluating a company's potential.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/08/2025 | Date of the transaction: Phillip Frost purchased 125,000 shares of OPKO Health, Inc. |
Keywords
OPKO Health, Phillip Frost, Insider Trading, Stock Purchase, Beneficial Ownership, OPK, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.